Pneumodissection for Skin Protection in Image-Guided Cryoablation of Superficial Musculoskeletal Tumors

Abstract

Purpose

Pneumodissection is described as a simple method for preventing skin injury during cryoablation of superficial tumours.

Methods

Superficial tumour cryoablations performed from 2009 to 2015 were retrospectively reviewed. Pneumodissection was performed in 13 patients when the shortest tumour-skin distance was less than 25 mm. Indications were pain palliation (n = 9) and local tumour control (n = 4). Patients, target tumours, technical characteristics and complications up to 60 days post ablation were reviewed. The ice ball-skin distances with and without pneumodissection were compared by a paired t-test and further assessed for association with covariates using ANCOVA.

Results

Technical success for ablation was 12 of 13. The mean shortest tumour-skin distance was 15.0 mm (3.2 – 24.5 mm). The mean thickness of pneumodissection was 9.6 mm (5.2 – 16.6 mm) resulting in mean elevation of skin of 3.4 mm (1.2 – 5.3 mm). Mean shortest ice ball-skin distance after pneumodissection was 10.5 mm (4.2 – 19.7 mm). No infection or systemic air embolism was noted. No intraprocedural frostbite was observed.

Conclusion

Pneumodissection is feasible, effective and safe in protecting the skin during image-guided cryoablation of superficial tumours.

Introduction

Cryoablation is a well established technique for treatment of bone tumours [1–6]. This technique relies on image guided percutaneous placement of applicators into the tumour, and the Joule-Thompson principle of argon and helium gas to rapidly cool or thaw the tissue immediately around the applicator. A sudden drop of temperature exceeding −150°C or rise in temperature up to +33°C can be achieved. Cytotoxic effects occurr secondary to intracellular and interstitial crystal formation in a combination of freeze and thaw cycles [7].

Different from the various other ablation techniques such as radiofrequency ablation or microwave ablation, cryoablation creates an “ice ball” that offers the advantage of easy visibility on ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI) [8]. This allows for close monitoring of the ablation zone, and helps prevent damage to the healthy perilesional structures [9, 10]. However, even with visualization, protective measures are needed to prevent the ice ball from extending into the skin as a critical non-target structure (Figure 1). Skin ulcers created during ablation increase morbidity by being painful and may provide a route for direct extension of infection into the underlying necrotic tissues of the superficial ablation zone.

Figure-1.

a- A 69 year old male with painful lytic metastasis from basal cell carcinoma of skin to the posterior left 12^th rib (arrows) despite radiation treatment. b- Palliative cryoablation with two Endocare Perc-24 applicators (only one is shown). Extension of ice ball to overlying skin is visible (arrows). This is despite utilization of topical warm compress (arrowheads). Freezing of skin was evident intraprocedurally and a non-blanching bruise developed at the conclusion of cryoablation. A 2 cm skin ulcer developed at this site later and resolved with wound care and conservative management. This patient is not among the study group.

Local warm compress applied by physically placing a warm heat source on the skin commonly becomes less effective by the presence of interventional devices in the field and by non-horizontal anatomic angles that work against gravity (Figures 2 and 3). Although CO₂ is used in pneumodissection in the peritoneal cavity to protect other organs, it has not been fully studied as a buffer to protect skin. Its handling is cumbersome, and its rapid absorption requires repeated injections and makes formation of a cushion of gas in subcutaneous tissues unlikely (Figure 3). Saline has a higher thermal conductivity than gas, which can result in the ablation zone extending to the skin [11]. It obscures tumour margins on CT imaging which may negatively affect technical outcomes of ablation. In many instances where protection of skin is deemed inadequate with local warm compress alone and intraprocedural imaging mandate immediate action to avoid frostbite, pneumodissection may be considered as the fastest remedy as it literally needs no additional equipment or time to apply.

Figure-2.

a- A 66 years old male with painful lytic metastasis from renal cell carcinoma to the left scapular blade (arrows). This lesion is painful despite radiation treatment. b- Two Endocare Perc-24 applicators are in place (only one is shown). c- Pneumodissection is done while the probes are on stick mode. Arrows show resultant subcutaneous emphysema. Topical warm compress is also in place (arrowhead). Note the inadequate contact of warm compress with skin due to presence of applicator and the non horizontal angle of skin. d- Full size ice ball toward the end of the second freeze cycle (arrows) could have extended to the overlying skin in the absence of pneumodissection. Originally injected pneumodissection has not changed significantly in the approximately 1 hour duration of this ablation intervention. There was no need to repeat pneumodissection throughout this intervention. Low quality of procedural images is due to utilization of low mA to reduce radiation dose to the patient.

Figure-3.

Therapeutic cryoablation in a 71-year-old patient with history of adenocarcinoma of lung and 2 prior biopsy-proven bone metastases treated with percutaneous ablation. a- PET/CT study shows a small sclerotic FDG avid (PET image not shown) lesion in the left eighth rib (arrow) thought to represent a metastasis. b- Intraprocedural CT image with the patient in supine position immediately prior to initiation of cryoablation. A single Endocare Perc-17 cryo applicator is in position. Since gas dissection with CO₂ was planned to push stomach and the splenic flexure of colon away from target tumour, the same mechanism was chosen to protect skin. A 5 French Yueh Centesis Catheter (Cook Medical, Bloomington, Indiana, USA) is in place (arrow) for peritoneal CO₂ gas dissection. A 25-gauge needle was used for subcutaneous CO₂ pneumodissection. About 0.5 L CO₂ was used for peritoneal dissection and about 50 mL CO₂ was used for subcutaneous dissection (asterisks). Subcutaneous CO₂ pneumodissection elevated the skin 2.5 mm, however no contiguous gas pads were discernible. Peritoneal pneumodissection was repeated one more time with the same volume and subcutaneous pneumodissection was repeated 2 more times during the intervention. c- CT image immediately after removal of cryo applicator and Yueh catheter at the conclusion of cryoablation about 60 minutes later. Tract of cryo-applicator in residual ice ball is visible (solid arrow). Peritoneal dissection has significantly absorbed (asterisk) and subcutaneous dissection is no longer discernible. Local warm compress is in place (dotted arrow).

The aim of this article is to describe pneumodissection technique as a simple method for preventing skin injury during cryoablation of superficial tumours.

Methods

Institutional Review Board waiver of consent was obtained for this retrospective study. All image guided cryoablations of soft tissue and bone tumours performed during a 75 months period of 01/2009 through 03/2015 were reviewed to identify lesions close to the skin for which pneumodissection was utilized. Images taken during the procedure were evaluated for the following parameters: utilization of pneumodissection, target lesion size and location, shortest distance between target lesion and skin before pneumodissection, maximum ice ball size, elevation of skin over the tumour by pneumodissection, thickness of pneumodissection air cushion in the overlying subcutaneous tissues, shortest distance between ice ball and skin after pneumodissection, as well as technical details of each ablation (Figure 4). All cryoablations were performed with general ana esthesia under CT, PET/CT or MRI guidance using Endocare (Endocare, Inc., Austin Texas, USA) or Galil Medical (Galil Medical Inc., Arden Hills, Minnesota, USA) systems. Ten cases were performed under CT guidance (Figures 2 and 4), 2 under MR guidance (Figure 5) and one under PET/CT guidance. Per institutional standard practice, all patients were given one dose of prophylactic IV antibiotics (cefazolin, or ciprofloxacin if allergic to cefazolin) to cover skin flora. No additional antibiotics were given. As a standard practice, local warm compress (Instant Hot Pack, Cardinal Health, McGaw Park, Illinois, USA) in a sterile shower cap was utilized for all patients.

Figure-4.

Palliative cryoablation in a 54-year-old female patient with metastatic breast cancer. a-Initial intraprocedural CT imaging with the patient in prone position. The target tumour is a 2.5 cm lytic metastasis in the right posterior iliac bone (white arrow). The solid straight line measures the closest distance between the tumour and the skin (14.7 mm). b- Two Endocare Perc-24 applicators are partially seen in this image (white arrows). Local warm compress is in place (dotted arrow). The applicators are intentionally placed at a shallow angle into the tumour to avoid extension of the ice ball into the skin along their shafts. Pneumodissection is in place (the asterisks). The solid straight line measures the new closest distance between the tumour and the skin (19.1 mm). Pneumodissection has resulted in 4.6 mm elevation of skin. The average thickness of subcutaneous air cushion measured at least in two points is 8 mm (dotted line showing one point of measurement). No additional air injection was needed throughout this intervention. c- Post procedure CT image immediately after removal of applicators approximately one hour after initial pneumodissection. Residual ice ball is visible (white arrows). Pneumodissection is still in place (asterisks). Local warm compress is in place (dotted arrow). This cryoablation was technically successful with no complications and successful clinical outcome.

Figure-5.

MR-guided cryoablation in a 47-year-old male with a subcentimeter painful right scapular lesion. a- axial post-gadolinium fat-saturated T1-weighted image in supine position shows an 8 mm lobulated, well-defined, enhancing, very T2-hyperintense (not shown) mildly expansile lesion in medial border of mid scapular body which has been stable in the past 2 years (arrow). It was thought to possibly represent enchondroma or fibrous dysplasia. Due to its size, location and stability, ablation was planned without biopsy. b- The patient is in prone position. An IceSeed Galil cryo applicator (asterisk) is positioned abutting the lateral aspect of the lesion in mid scapular body (arrow). No attempt was made to drill into the bone as the ice ball was expected to grow into the bone and include the lesion. c- Pneumodissection in place (asterisks) toward the end the single planned freeze cycle. Local warm compress is in place as our standard practice. Flattening of the surface of ice ball where it contacts air is evident (arrows). This is a visual confirmation of efficient thermal resistance of air.

Pneumodissection Technique: Pneumodissection was used when the shortest distance between the target lesion and overlying skin was 25 mm or less and the intended size of the ice ball could potentially reach the skin. Considering uncertainties about the final size of ice ball which could be affected by variables such as applicator size, number, approach and tissue vascularity, the arbitrary 25 mm distance was thought to include most scenarios where ice ball could potentially reach the skin. Pneumodissection was performed after placement of all applicators (on “stick” mode) and obtaining the first set of procedural images. Approximately 10–20 mL room air was gently injected into the subcutaneous tissues under the skin overlying the prospective area of ice ball formation using a syringe and a 25 or 30 gauge needle. Proper depth of injection was visually confirmed by immediate elevation of skin upon injection. The number of punctures was decided at the discretion of operator so the skin elevation is visibly covering the area over ablation zone. Typically two punctures were enough for most cases. No local anaesthesia was given for pneumodissection. The same syringe and needle used for local anaesthesia for cryo probe placement was usually used for pneumodissection. The minimum acceptable thickness of injected air within subcutaneous tissues was arbitrarily set to 3 mm. Based on routine intra procedural imaging; additional air was injected to maintain the minimum thickness if needed. No thermocouple was used to monitor the skin temperature since integrity of the skin could be monitored by intermittent imaging and physical examination intraprocedurally. Intraprocedural frostbite was defined with the presence of any of the three criteria; 1- extension of ice ball to skin on intraprocedural images. 2- freezing of skin on intraprocedural physical examination where the skin becomes rigid. 3 — presence of a non-blanching bruise over the area of ice ball No microparticle filter was used although our operating rooms are equipped with a ventilation system with five levels of filtration including two levels of high-efficiency particulate arrestance (HEPA) filters.

Technical success of ablation was defined as the ability to execute the ablation as planned preprocedurally.

A 5 mm safe minimum distance between ice ball and skin was set arbitrarily based on common recommendation for a 5–10 mm minimum displacement to protect critical organs from collateral damage in thermal ablation interventions.

All ablation patients are seen in Interventional Radiology (IR) clinic 45–60 days post procedure with a contrast-enhanced CT or MRI study. The electronic medical records were reviewed up to 60 days past the date of procedure to assess complications. These included all visits, hospital admissions, notes, phone communications as well as laboratory and imaging results. Special attention was paid to capture information related to local or systemic infections and skin, neurologic or respiratory issues within this period.

Statistical Analysis

Patient demographics, tumour characteristics and ablation parameters were recorded for each case. Means and medians were estimated for tumours’ greatest dimension, minimum distance from skin before pneumodissection, elevation of skin with pneumodissection, as well as maximum diameter of ice ball and minimum distance of ice ball from skin after pneumodissection. The presumed distance without pneumodissection was calculated by subtracting the thickness of pneumodissection from the minimum distance between ice ball and skin with pneumodissection in place. An exact Wilcoxon signed rank test was used to evaluate whether the median ice ball-skin distances with and without pneumodissection were significantly different; this is equivalent to testing whether the median thickness of pneumodissection was significantly different from zero. We also examined the association of these distance measures with tumour distance from skin, tumour size and tumour location graphically using scatter plots and box plots. We evaluated the association of median thickness of pneumodissection with these tumour characteristics using an exact Kruskal Wallis test. For analysis purposes, tumour size and tumour distance from skin were dichotomized at the median. Analyses were based on all 13 patients, which included a single technical failure in which pneumodissection was used but the cryoablation could not be completed as planned for an intent-to-treat analysis. P < 0.05 was considered statistically significant. All analyses were performed using SAS version 9.4 (Cary, NC).

Results

Patient demographics and technical characteristics of the study group are listed in Table 1. Thirteen patients (male n = 9, female n = 4) with the mean age of 59 years (3–79 years, median 64 years) were included in this study. The majority of lesions were metastases (n = 11) with one recurrent sarcoma and one benign bone lesion (enchondroma or fibrous dysplasia). The indications were palliation of pain (n = 8), local control (n = 3) or both (n = 1). The tumours had a mean diameter of 37.2 mm (10.0 – 71.1 mm, median 33.73 mm). The mean shortest distance between the lesion and the skin was 15.0 mm (3.2 to 24.5 mm; median 15.7 mm). The mean elevation of skin by pneumodissection was 3.4 mm (1.2 – 5.3 mm, median 3.3 mm). The mean thickness of pneumodissection air cushion in the overlying subcutaneous tissues was 9.6 mm (4.9–16.6 mm, median 9.5 mm). The elevation of skin was not equal to the thickness of the pneumodissection layer. This is probably due to the less dense air replacing denser soft tissues.

Table 1.

Patient demographics and technical characteristics.

Patient	Age	Sex (F: female, M: male)	Tumor Pathology	Tumor Location (R: right, L: left)	Tumor Greatest Dimension (mm)	Tumor Minimum Distance to Skin (mm)	Elevation of Skin with Pneumodissection (mm)	Thickness of Pneumodissection (mm)	Ice Ball Maximum Diameter (mm)	Ice Ball Minimum Distance to Skin (mm)++	Ice Ball Minimum Distance to Skin (mm)+++	Imaging Guidance	Freeze (F)–Thaw(T) Cycles	Freeze –Thaw Duration (minutes)	Number of applicators	Overlapping ablations	Ablation Technical Success	Ablation System
1	53	F	Breast ca	R iliac bone	24.2	15.7	4.6	8.0	53.6	11.2	3.2	CT	F-T-F-T	10-8-6-6	2	2	Yes	Endocare
2	78	F	Uterine ca	Abdominal wall	38.8	15.2	1.2	16.6	63.1	19.7	3.1	MRI	F-T-F-T	12-8-8-8	2	2	Yes	Galil
3	61	M	NSCLC	L chest wall	48.4	24.5	2.0	10.2	48.2	19.2	9.0	CT	F-T-F-T	10-8-6-8	2	4	Yes	Endocare
4*	76	F	CRC	L 7th and 8th ribs	33.7	3.2	3.3	5.2	45.2	6.7	3.5	CT	F-T	12-8	2	2	No	Endocare
5	79	M	NSCLC	R 7–9th ribs	63.9	20.0	3.8	9.5	149.1	7.3	−2.2	CT	F-T-F-T	12-8-12-8	3	6	Yes	Endocare
6	65	M	RCC	R scapula	49.3	9.0	4.0	5.7	61.1	9.2	3.5	CT	F-T-F-T	14-8-6-6	2	2	Yes	Endocare
7	64	M	Liposarcoma	Abdominal wall	27.6	8.9	5.3	14.9	46.8	15.6	0.7	CT	F-T-F-T	12-8-8-8	1	1	Yes	Endocare
8	47	M	Benign+	R scapula	13.9	10.1	3.2	4.9	40.5	4.2	−0.5	MRI	F-T	12-8	1	1	Yes	Galil
9	62	M	Prostate ca	R iliac bone	43.7	21.8	4.4	10.1	59.9	8.9	−1.2	PET/CT	F-T-F-T	14-8-8-8	2	2	Yes	Endocare
10	3	M	Neuroblastoma	L proximal tibia	28.5	10.1	4.8	6.7	40.4	7.4	0.7	CT	F-T-F-T	12-8-6-8	2	2	Yes	Endocare
11**	66	M	Prostate ca	L 6th rib	71.1	21.0	2.0	13.3	82.1	11.7	−1.6	CT	F-T-F-T	10-8-10-8	4	7	Yes	Endocare
12	36	M	Sarcoma	L distal thigh	10.0	19.0	3.3	9.6	35.2	5.0	−4.6	CT	F-T-F-T	10-8-8-8	1	2	Yes	Galil
13	71	F	RCC	R scapula	31.1	16.0	2.1	9.5	56.0	10.6	1.1	CT	F-T-F-T	12-8-6-4	2	2	Yes	Endocare

NSCLC: non-small cell lung carcinoma. CRC: colorectal carcinoma. ca: cancer. RCC: renal cell carcinoma.

^*: Ablation could not be completed as planned due to irresolvable adhesion of target tumor to adjacent colon.

⁺: Diagnosis of enchondroma vs fibrous dysplasia was made based on stability and MRI and CT findings. No biopsy was done.

^**: This patient developed moderate left pleural effusion requiring thoracentesis 6 days after ablation. Cytology and culture of the fluid were negative.

⁺⁺: Measured with pneumodissection in place.

⁺⁺⁺: Measured without pneumodissection in place (at the original level of skin).

The mean maximum diameter of the ice ball was 60.1 mm (35.2 – 149.1 mm; median 53.6 mm). The mean shortest distance between ice ball edge and skin after pneumodissection was 10.5 mm (4.2 – 19.2 mm; median 9.2 mm). When comparing ice ball and skin distance with and without pneumodissection in place, the difference was significant or equivalently the thickness of pneumodissection was significantly different from zero (p<0.001), suggesting that the minimum acceptable air pocket thickness was successfully maintained during the cryoablation. In all but one patient, the presumed distance without pneumodissection was less than 5mm. This 5 mm distance may represent a ‘safe’ minimum distance between ice ball to skin as no patients experienced intraprocedural frostbite in this case series. Without pneumodissection, the predicted ice ball to skin distance would be less than 5 mm in 12 of 13 cases (Figure 6). Tumour distance from skin, tumour size, and anatomic location were not significantly associated with median thickness of pneumodissection.

Figure-6.

Dot plot of minimum ice ball-skin distance with and without pneumodissection with means and standard deviations. The ice ball to skin distance without pneumodissection was calculated by subtracting the thickness of the pneumodissection layer from the ice ball to skin distance with pneumodissection. The dotted line depicts a potential “safe” minimum 5 mm distance between ice ball and skin. In the absence of pneumodissection all but one ice ball breach the safe distance toward the skin and five ice balls grow through the skin (0 mm point).

Technical details of ablation interventions including the number of applicators, the systems used, number of freeze-thaw cycles and the duration of cycles are outlined in Table 1. In cases where the applicators provided temperature readings (Endocare), cytotoxic temperatures were achieved within a range of −120°C to −159°C. In cases where the applicators did not provide temperature reading (Galil), a thermocouple was not used and adequacy of ablation was assessed by imaging confirmation of progression of ice ball to include the target tumour and intended margin.

Pneumodissection was required only once at the start of the intervention for 11 patients. Additional pneumodissection (10–20 mL) to maintain the minimum 3 mm thickness of subcutaneous air was needed during cryoablation in two patients with prolonged intervention times of more than 120 minutes (patients 4 and 5, table 1).

No infection or systemic air embolism was noted in any patients (0/13). No intraprocedural frostbite was noted in any of the study patients(0/13).

In one patient with technically unsuccessful palliative cryoablation of a left posterior lateral rib metastasis (patient 4, table 1), despite lack of intraprocedural frostbite, a 2 cm non-blanching bruise was noted on the skin the next day. This turned into a shallow ulcer on follow-up visit 9 days after ablation. The ablation could not be executed as planned due to irresolvable adhesion of tumour to the splenic flexure of colon requiring several time-consuming manoeuvres. We hypothesized that the residual ice ball at the conclusion of ablation damaged the overlying skin during the recovery period when the patient was lying on this site. Patient’s comorbidities such as diabetes, coronary artery disease, cachectic body habitus and chemotherapy-induced mucusitis may have contributed to formation of a skin ulcer. The ulcer was healed with conservative management (SIR complication class minor B).

A patient with prostate cancer and cryoablation of a painful left 6th rib metastasis developed moderate left pleural effusion requiring thoracentesis 6 days after ablation. (SIR complication class minor B).

Discussion

Percutaneous ablative techniques have evolved into a useful modality for treatment or palliation of tumours of the musculoskeletal system [12]. These techniques include chemical ablation (ethanol or acetic acid), laser ablation, radiofrequency ablation, microwave ablation, cryoablation, high intensity focused ultrasound and irreversible electroporation. In the application of these techniques, it is imperative to take measures to protect the critical non-target structures in the vicinity of the target lesion.

Common non-target critical structures in body IR domain include skin, bowel and nerves. A variety of protective measures are available, including gas dissection, hydrodissection and warming/cooling compressions for skin protection. Protection may also be achieved by continuous temperature monitoring in the area using thermocouples, and by monitoring of nerve at risk using neurodiagnostic EEG, EMG and evoked potential electrodes with accessories [13]. Some protective measures are planned in advance and some are required on an urgent basis during an ablation intervention. The various protective techniques carry unique advantages and disadvantages and defining their specific applicability in the different clinical settings is important [14].

Skin ulcers created during ablation are painful and may provide a route for direct extension of infection into the necrotic tissues of the superficial ablation zone. It is likely that the prevalence of intraprocedural frostbite is underreported as the integrity of skin is shadowed by the primary objective of a cryoablation intervention [15]. Currently the common practice for protecting the overlying skin during cryoablation is to use hydrodissection with saline or lidocaine, gas dissection with CO₂ and local warm compress [1–3, 6, 15].

Local warm compression is the easiest and least expensive method. However, due to the presence of physical obstacles in the ablation region, including cryoablation applicators, asymmetric shapes of the heat containers (i.e. gloves) and anatomic challenges of keeping the source of heat on the skin in non-horizontal angles, warm compress alone cannot protect the skin (Figures 1 and 2). Saline is easy to apply. It may need to be warmed before use which adds another step to its utilization. The limitations of using saline are that it may freeze and extend the ice ball to the skin [1, 15]. Additionally, it obscures tumour margins on CT imaging, which may negatively affect technical outcomes of ablation [15]. Addition of diluted water soluble contrast material to saline may be needed to overcome this problem.

Gas buffers such as CO₂ and air work by two mechanisms; 1- displacing the skin away from the ice ball and 2- decreasing the subcutaneous tissue’s thermal conductivity (cushion of gas replacing water-containing soft tissues).

Both CO₂ and air are easily visible on CT and MRI and are excellent insulators, each having a much lower thermal conductivity than water (saline). The thermal conductivity of CO₂, air and water are 0.014 – 0.016 W/m.K, 0.024 – 0.025 W/m.K and 0.56 – 0.59 W/m.K respectively [11]. Compared to air, CO₂ is relatively expensive, cumbersome to use and requires repeated injections due to its rapid absorption rate. Air is readily available, free of charge and does not require special handling or equipment for delivery.

Hypothetical arguments against the use of pneumodissection have included 1) CO₂ being a better insulator than air (0.014 – 0.016 W/m.K for CO2 vs. 0.024 – 0.025 W/m.K for room air), and 2) the potential risk of infection and air embolism associated with air. Given that the difference in thermal conductivity between CO₂ and air is small but both are much lower than water (20–40 times), we expect no major difference in the effectiveness of either material in protecting the skin from freezing. Rapid solubility of CO₂ probably makes it unlikely to form a cushion of gas in the subcutaneous tissues and requires repeated injections during an ablation intervention (Figure 3). This is unlikely with air. Hypercarbia along with other complications from utilization of CO₂ in laparoscopic surgeries have been reported and can be of concern in select patients with poor respiratory reserve [16]. Awareness of this issue when planning cryoablation in patients with poor respiratory reserve is important.

Two of the potential complications of injecting air into the subcutaneous tissue and causing iatrogenic subcutaneous emphysema are air embolization and infection. A review of the literature on iatrogenic subcutaneous emphysema originating from lung procedures shows that air embolism and infection are extremely rare [17–22]. The air even in large volumes is expected to reabsorb over time once the underlying problem is resolved.

Approximately 10–40 ml of air was injected in the patients in this case series. Therefore, when compared to reported cases of subcutaneous emphysema, the volume of air used in our case series is significantly smaller. Additionally, the air used for pneumodissection is the operating room air, which has been through several layers of filtration and injected under sterile percussions. Therefore, theoretically operating room air used for pneumodissection is more purified compared to ordinary air. For the above reasons, systemic air embolism and infection are expected to be extremely unlikely from intraprocedural pneumodissection as described here. Pneumodissection has been reported as a protective technique in cryoablation of small renal masses [23].

Utilization of air as an ingredient of foam sclerotherapy in different organs such as venous vascular malformations, varicocele and portal vein among others is well reported in the literature [24–27]. Utilization of air in subcutaneous tissues for pneumodissection should not carry higher risk for complications compared to its accepted use in foam sclerotherapy in other organs. In this case series, none of the patients developed infection or air embolization.

One patient in this series developed a frostbite during recovery period while lying supine on the residual iceball. Comorbidities such as cachectic body habitus, mucusitis and irresolvable adhesions probably facilitated this outcome. Based on this case and another patient with the same outcome (not in this series), we changed our standard practice such that all patients who undergo superficial cryoablation will receive local warm compress throughout the recovery period. Also organ displacement will be performed first before initiation of cryoablation to avoid complications from irresolvable adhesions.

This study has several limitations including its retrospective design, lack of a control group and the small patient population.

Pneumodissection technique is readily available and easy to use when protection of skin is urgently needed, particularly when rapid unexpected growth of ice ball is detected on intra procedural images.

In conclusion, pneumodissection can be added to the armamentarium of interventional radiologists as an easy and readily available method for skin protection during image guided percutaneous cryoablation of superficial musculoskeletal tumours. Based on this small case series, pneumodissection is recommended when the lesion is 2.5 cm close to the skin surface. Additionally, pneumodissection of 10 mm that results in average of 3.4 mm of skin elevation can effectively prevent skin injury during image-guided cryoablation of superficial bone and soft tissue tumors.

Key Points.

• -Frostbite during image guided cryoablation of superficial tumours is commonly underreported.
• -Frostbites are painful and may introduce infection into the superficial ablation zone.
• -Warm compress, saline and CO2 have shortcomings in protecting the skin.
• -Pneumodissection is free, readily available, easy to use and safe and effective.